Modulating cellular metabolic response is therefore likely one of the means through which MR and RAR signalling exert their anti-proliferative effect in breast cancer, and it will be important now to further validate our findings using additional in vitro studies. The gene discussed is NR3C2; the disease is breast carcinoma.